A blog about chemistry, drug development, science, and technology
Pages (999999): [1] 2 3 » ... Last »
Newsday has an article that illustrates how tough it is to deal with conflicts of interest in this case between advocacy groups and the pharmaceutical companies.
Drug company payments to advocates an issue - Newsday.com:
While the FDA has cracked down on advisory committee members and their ties to drug companies, the same rules do not apply to advocacy groups. This can lead to a variety of problems and could lead to so called “turf groups” that is advocacy groups that are really just lobbying group for the drug companies.
I fully understand that these advocacy groups need money to survive and that they get money form the drug industry. However, it is hard for me to believe when they say there is no conflict of interest if they are unwilling to reveal who is giving how much.
The rules for conflict of interest are not clear and seemingly not very effective in many cases leaving this open for abuses in the future.
Technorati Tags: conlficts of interest
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
Pages (999999): [1] 2 3 » ... Last »
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 2.656 seconds